- Home
- AQST vs STIM Comparison
AQST vs STIM Comparison
Compare AQST & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQST
- STIM
- Stock Information
- Founded
- AQST 2004
- STIM 2003
- Country
- AQST United States
- STIM United States
- Employees
- AQST N/A
- STIM N/A
- Industry
- AQST Biotechnology: Pharmaceutical Preparations
- STIM Medical/Dental Instruments
- Sector
- AQST Health Care
- STIM Health Care
- Exchange
- AQST Nasdaq
- STIM Nasdaq
- Market Cap
- AQST 254.1M
- STIM 232.3M
- IPO Year
- AQST 2018
- STIM 2018
- Fundamental
- Price
- AQST $2.51
- STIM $3.76
- Analyst Decision
- AQST Strong Buy
- STIM Buy
- Analyst Count
- AQST 6
- STIM 4
- Target Price
- AQST $11.17
- STIM $6.00
- AVG Volume (30 Days)
- AQST 1.4M
- STIM 1.1M
- Earning Date
- AQST 05-06-2025
- STIM 05-06-2025
- Dividend Yield
- AQST N/A
- STIM N/A
- EPS Growth
- AQST N/A
- STIM N/A
- EPS
- AQST N/A
- STIM N/A
- Revenue
- AQST $57,561,000.00
- STIM $74,890,000.00
- Revenue This Year
- AQST N/A
- STIM $102.36
- Revenue Next Year
- AQST $39.51
- STIM $9.83
- P/E Ratio
- AQST N/A
- STIM N/A
- Revenue Growth
- AQST 13.79
- STIM 4.96
- 52 Week Low
- AQST $2.20
- STIM $0.52
- 52 Week High
- AQST $5.80
- STIM $5.92
- Technical
- Relative Strength Index (RSI)
- AQST 41.88
- STIM 45.71
- Support Level
- AQST $2.20
- STIM $3.46
- Resistance Level
- AQST $2.61
- STIM $4.14
- Average True Range (ATR)
- AQST 0.22
- STIM 0.40
- MACD
- AQST -0.03
- STIM -0.00
- Stochastic Oscillator
- AQST 36.47
- STIM 56.52
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About STIM Neuronetics Inc.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.